메뉴 건너뛰기




Volumn 54, Issue 11, 2011, Pages 2963-2964

High serum potassium levels after using losartan can reflect more severe renal disease

Author keywords

Hyperkalaemia; Inhibitors of the renin angiotensin system; Renal disease progression; Tubulointerstitial damage

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN; LOSARTAN; POTASSIUM; PROTEIN;

EID: 80054708018     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2220-7     Document Type: Article
Times cited : (10)

References (7)
  • 1
    • 79953787215 scopus 로고    scopus 로고
    • Increased serum potassium affects renal outcomes: A post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
    • 20882268 10.1007/s00125-010-1922-6 1:CAS:528:DC%2BC3cXhsFWqtLvF
    • Y Miao D Dobre HJ Lambers Heerspink, et al. 2011 Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial Diabetologia 54 44 50 20882268 10.1007/s00125-010-1922-6 1:CAS:528: DC%2BC3cXhsFWqtLvF
    • (2011) Diabetologia , vol.54 , pp. 44-50
    • Miao, Y.1    Dobre, D.2    Lambers Heerspink, H.J.3
  • 2
    • 0035922441 scopus 로고    scopus 로고
    • Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    • 11565518 10.1056/NEJMoa011161 1:CAS:528:DC%2BD3MXntlelsLk%3D
    • BM Brenner ME Cooper D de Zeeuw, et al. 2001 Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 861 869 11565518 10.1056/NEJMoa011161 1:CAS:528: DC%2BD3MXntlelsLk%3D
    • (2001) N Engl J Med , vol.345 , pp. 861-869
    • Brenner, B.M.1    Cooper, M.E.2    De Zeeuw, D.3
  • 3
    • 0032932026 scopus 로고    scopus 로고
    • Erythropoietin deficiency in hyporeninemia
    • S Donnelly BR Shah 1999 Erythropoietin deficiency in hyporeninemia Am J Kidney Dis 33 947 953 10213654 10.1016/S0272-6386(99)70431-2 1:STN:280:DyaK1M3jtVWlug%3D%3D (Pubitemid 29214695)
    • (1999) American Journal of Kidney Diseases , vol.33 , Issue.5 , pp. 947-953
    • Donnelly, S.1    Shah, B.R.2
  • 5
    • 0025829825 scopus 로고
    • The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis
    • 2068008 1:STN:280:DyaK3M3ps1KgsQ%3D%3D
    • A Bohle M Wehrmann O Bogenschutz C Batz CA Muller GA Muller 1991 The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis Pathol Res Pract 187 251 259 2068008 1:STN:280:DyaK3M3ps1KgsQ%3D%3D
    • (1991) Pathol Res Pract , vol.187 , pp. 251-259
    • Bohle, A.1    Wehrmann, M.2    Bogenschutz, O.3    Batz, C.4    Muller, C.A.5    Muller, G.A.6
  • 6
    • 33644530729 scopus 로고    scopus 로고
    • ACE-inhibitor use and the long-term risk of renal failure in diabetes
    • 16518351 10.1038/sj.ki.5000159 1:CAS:528:DC%2BD28Xhs1Kitrg%3D
    • S Suissa T Hutchinson JM Brophy A Kezouh 2006 ACE-inhibitor use and the long-term risk of renal failure in diabetes Kidney Int 69 913 919 16518351 10.1038/sj.ki.5000159 1:CAS:528:DC%2BD28Xhs1Kitrg%3D
    • (2006) Kidney Int , vol.69 , pp. 913-919
    • Suissa, S.1    Hutchinson, T.2    Brophy, J.M.3    Kezouh, A.4
  • 7
    • 49149087718 scopus 로고    scopus 로고
    • Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): A multicentre, randomised, double-blind, controlled trial
    • Johannes FM, Schmieder RE, McQueen M et al (2008) Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372:547-553
    • (2008) Lancet , vol.372 , pp. 547-553
    • Johannes, F.M.1    Schmieder, R.E.2    McQueen, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.